Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Zydus to commercialize Vascular Endothelial Growth Factor inhibitor Nufymco in US

Biocon Biologics secures US market entry date for Bmab 1200, a Proposed Biosimilar to Stelara

Ruchika Sharma1 March 2024 3:30 PM IST

Stelara (Ustekinumab) is a monoclonal antibody medication that prevents abnormal regulation of interleukin IL-12/23 associated immune diseases and has...

Sandoz to acquire Just-Evotec Biologics EU SAS in-house development, manufacturing capabilities in France for USD 300 million

Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs

Ruchika Sharma1 March 2024 3:03 PM IST

Basel: Sandoz Inc. and its subsidiary Fougera Pharmaceuticals Inc. (together, "Sandoz US") - both indirect subsidiaries of Sandoz Group AG - have...

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

USFDA issues 7 observations for Aurobindo Pharma arm Telagana injectable facility

Ruchika Sharma1 March 2024 2:00 PM IST

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has concluded an inspection with 7...

Biocon Gets USFDA Approval for Everolimus Oral Suspension in Pediatric, Adult TSC

Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations

Ruchika Sharma1 March 2024 12:01 PM IST

Bangalore: Biocon has recently announced that the U.S. Food and Drug Administration (USFDA) has issued Form 483s with 4 observations at...

Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma

Roche Pharma unveils multiple sclerosis treatment drug Ocrevus in India

Ruchika Sharma29 Feb 2024 5:00 PM IST

New Delhi: Roche Pharma India has launched a drug for the treatment of Multiple Sclerosis (MS), expanding its neurology portfolio to cater...

Biological E, Takeda join hands to accelerate access to Dengue Vaccine in endemic areas

Ruchika Sharma29 Feb 2024 3:00 PM IST

Hyderabad: Takeda and Biological E. Limited (BE), an India-based Vaccines and Pharmaceutical Company, has announced a strategic partnership...

Bayer new drug application for gadoquatrane accepted for review in China

Bayer gets USFDA Breakthrough Therapy designation for BAY 2927088 for non-small cell lung cancer harboring HER2 activating mutations

Ruchika Sharma29 Feb 2024 1:30 PM IST

BAY 2927088 was derived from Bayer's long-standing strategic research alliance with the Broad Institute of MIT and Harvard in Cambridge, MA, USA.

Eli Lilly Expands Immunology Pipeline with USD 1.2 Billion Ventyx Buyout

Eli Lilly expects to launch diabetes drug Mounjaro in India next year: CEO

Ruchika Sharma29 Feb 2024 12:30 PM IST

Mounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both conditions.

Granules India packaging facility in US successfully completes USFDA inspection

Alkem Labs gets USFDA EIR for Mandva facility

Ruchika Sharma29 Feb 2024 11:54 AM IST

Mumbai: Alkem Labs has announced that US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report (EIR) for the...

Zydus Lifesciences aims to launch first new drug in US by early 2026

Ruchika Sharma28 Feb 2024 4:30 PM IST

Ahmedabad: India's Zydus Lifesciences is aiming to launch its first new drug in the United States by early 2026, looking to tap into the...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

USFDA set to increase inspections at Indian drug manufacturing units

Ruchika Sharma28 Feb 2024 3:30 PM IST

FDA Country Director (India) said the Indian pharma industry needs to invest more in automation for better compliance.

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

Bristol Myers Squibb opens new USD 100 million facility in Hyderabad

Ruchika Sharma28 Feb 2024 1:30 PM IST

Hyderabad: Bristol Myers Squibb, one of the world's largest biopharmaceutical companies, has announced the opening of a new facility in...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok